Two human T cell receptors bind in a similar diagonal mode to the HLA- A2/Tax peptide complex using different TCR amino acids

Immunity

Volumn 8, Issue 4, 1998, Pages 403-411

  Ding, Yuan Hua ^a   Smith, Kathrine J ^b   Garboczi, David N ^d   Utz, Ursula ^c   Biddison, William E ^d   Wiley, Don C ^a,b  

^a HARVARD UNIVERSITY   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; HLA A2 ANTIGEN; T LYMPHOCYTE RECEPTOR; TAX PROTEIN;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; HUMAN; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE;

EID: 18344405559     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80546-4     Document Type: Article

References (44)

1. Arden, B., Clark, S.P., Kabelitz, D., and Mak, T. (1995). Human T-cell receptor variable gene segment families. Immunogenetics 42, 455-500.
2. Bentley, G.A., Boulot, G., Karjalainen, K., and Mariuzza, R.A. (1995). Crystal structure of the beta chain of a T cell antigen receptor. Science 267, 1984-1987.
3. Blomberg, K., Hautala, R., Lovgren, J., Mukkala, V.-M., Lindqvist, C., and Akerman, K. (1996). Time-resolved fluorometric assay for natural killer activity using target cells labelled with a fluorescence enhancing ligand. J. Immunol. Methods 193, 199-206.
4. Brown, J.H., Jardetzky, T.S., Gorga, J.C., Stern, L.J., Urban, R.G., Strominger, J.L., and Wiley, D.C. (1993). The three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364, 33-39.
5. Brünger, A.T. (1992). Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 255, 472-475.
6. Carson, M. (1991). Ribbons 2.0. J. Appl. Crystallogr. 24, 958-961.
7. Collins, E.J., Garboczi, D.N., and Wiley, D.C. (1994). Three dimensional structure of a peptide extending out one end of a class I MHC binding site. Nature 371, 626-629.
8. Elovaara, I., Koenig, S., Brewah, A.Y., Woods, R.M., Lehky, T., and Jacobson, S. (1993). High human T-cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J. Exp. Med. 177, 1567-1573.
9. b. Science 257, 919-927.
10. Garboczi, D.N., Ghosh, P., Utz, U., Fan, Q.R., Biddison, W.E., and Wiley, D.C. (1996a). Structure of the complex between human T cell receptor, viral peptide, and HLA-A2. Nature 384, 134-141.
11. Garboczi, D.N., Utz U., Ghosh, P., Seth, A., Kim, J., van Tienhoven, A.E., Biddison, W.E., and Wiley, D.C. (1996b). Assembly, specific binding, and crystallization of a human TCR-αβ with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2. J. Immunol. 157, 5403-5410.
12. Garcia, K.C., Degano, M., Stanfield, R.L., Brunmark, A., Jackson, M.R., Peterson, P.A., Teyton, L., and Wilson, I.A. (1996). Structure of an αβ T cell receptor at 2.5 Å and its orientation in the TCR-MHC complex. Science 274, 209-219.
13. Garcia, K.C., Degano, M., Pease, L.R., Huang, M., Peterson, P.A., Teyton, L., and Wilson, I.A. (1998). Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 279, 1166-1172.
14. Guo, H.-C., Jardetzky, T.S., Garrett, T.P.J., Lane, W.S., Strominger, J.L., and Wiley, D.C. (1992). Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature 360, 364-366.
15. Hampl, J., Chien, Y.-h., and Davis, M.M. (1997). CD4 augments the response of a T cell to agonist but not to antagonist ligands. Immunity 7, 379-385.
16. Janeway, C.A., Jr., Dianzani, U., Portoles, P., Rath, S., Reich, E.-P., Rojo, J., Vagi, J., and Murphy, D.P. (1989). Cross-linking and conformational change in T-cell receptors: role in activation and in repertoire selection. Cold Spring Harb. Symp. Quant. Biol. 54, 657-666.
17. Jones, T.A., Zou, J.Y., Cowan, S.W., and Kjeldgaard, M. (1991). Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta. Crystallogr. A 47, 110-119.
18. Kraulis, P. (1991). MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 924-950.
19. Lyons, D.S., Lieberman, S.A., Hampl, J., Boniface, J.J., Chien, Y.-h., Berg, L.J., and Davis, M.M. (1996). A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 5, 53-61.
20. Madden, D.R., and Wiley, D.C. (1992). Peptide binding to the major histocompatibility complex molecules. Curr. Biol. 2, 300-304.
21. Madden, D.R., Gorga, J.C., Strominger, J.L., and Wiley, D.C. (1991). The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 353, 321-325.
22. Madden, D.R., Gorga, J.C., Strominger, J.L., and Wiley, D.C. (1992). The three-dimensional structure of HLA B-27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70, 1035-1048.
23. Madden, D.R., Garboczi, D.N., and Wiley, D.C. (1993). The antigenic identity of peptide/MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75, 693-708.
24. Matsumura, M., Fremont, D.H., Peterson, P.A., and Wilson, I.A. (1992a). Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257, 927-934.
25. Matsumura, M., Saito, Y., Jackson, M.R., Song, E.S., and Peterson, P.A. (1992b). In vitro peptide binding to soluble empty class I major histocompatibility complex molecules isolated from transfected Drosophila melanogaster cells. J. Biol. Chem. 267, 23589-23595.
26. Merritt, E.A., and Murphy, M.E.P. (1994). RASTER 3D, version 2.0, a program for photorealistic molecular graphics. Acta Crystallogr. D 50, 869-873.
27. Navaza, J., and Saludjian, P. (1997). AMoRe: an automated molecular replacement program package. Methods Enzymol. 276, 581-594.
28. Nicholls, A., Sharp, K.A., and Honig, B. (1991). Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281-296.
29. Reich, Z., Boniface, J.J., Lyons, D.S., Borochov, N., Wachtel, E.J., and Davis, M.M. (1997). Ligand-specific oligomerization of T-cell receptor molecules. Nature 387, 617-620.
30. Reid, S.W., McAdam, S., Smith, K.J., Klenerman, P., O'Callaghan, A., Harlos, K., Jakobsen, B.K., McMichael, A.J., Bell, J.I., Stuart, D.I., et al. (1996). Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J. Exp. Med. 184, 2279-2286.
31. Roman, G.C., and Osame, M. (1988). Identity of HTLV-1-associated tropical spastic paraparesis and HTLV-1-associated myelopathy. Lancet 1, 651.
32. Sant'Angelo, D.B., Waterbury, G., Preston-Hurlburt, P., Yoon, S.T., Medzhitov, R., Hong, S.-c., and Janeway, C.A.J. (1996). The specificity and orientation of a TCR to its peptide-MHC class II ligands. Immunity 4, 367-376.
33. Silver, M.L., Guo, H.-C., Strominger, J.L., and Wiley, D.C. (1992). Atomic structure of a human MHC molecule presenting an influenza virus peptide. Nature 360, 367-369.
34. Smith, K.D., and Lutz, C.T. (1997). Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices. J. Immunol. 158, 2805-2812.
35. Smith, K.J., Reid, S.W., Harlos, K., McMichael, A.J., Stuart, D.I., Bell, J.I., and Jones, E.Y. (1996a). Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity 4, 215-228.
36. 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity 4, 203-213.
37. Stern, L.J., and Wiley, D.C. (1994). Antigenic peptide binding by class I and class II histocompatibility proteins. Structure 2, 245-251.
38. Storkus, W.J., Howell, D., Salter, R., Dawson, J., and Cresswell, P. (1987). NK susceptibility varies inversely with target cell class I HLA expression. J. Immunol. 138, 1657-1659.
39. b molecule. Immunity 3, 573-582.
40. Teng, M.-K., Smolyar, A., Tse, A.G.D., Liu, J.-H., Liu, J., Hussey, R.E., Nathenson, S.G., Chang, H.-C., Reinherz, E.L., and Wang, J.-H. (1998). Crystal structure of the N15 TCR in complex with its peptide/ MHC (pMHC) ligand: identification of a common docking topology with substantial variation among different TCR-pMHC complexes. Curr. Biol. 8, 409-412.
41. + T-cell responses to human myelin protein-derived peptides. Proc. Natl. Acad. Sci. USA 91, 10859-10863.
42. + cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion. J. Virol. 70, 843-851.
43. Wang, J.-h., Lim, K., Smolyar, A., Teng, M.-k., Liu, J.-h., Tse, A.G.D., Liu, J., Hussey, R.E., Chishti, Y., Thomson, C.T., et al. (1998). Atomic structure of a αβ T cell receptor (TCR) heterodimer in complex with an anti-TCR Fab fragment derived from a mitogenic antibody. EMBO J. 17, 10-26.
44. b molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition. Proc. Natl. Acad. Sci. USA 89, 8403-8407.